These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Tedaldi EM; Baker RK; Moorman AC; Alzola CF; Furhrer J; McCabe RE; Wood KC; Holmberg SD; Clin Infect Dis; 2003 Feb; 36(3):363-7. PubMed ID: 12539079 [TBL] [Abstract][Full Text] [Related]
44. [HIV infection: emerging issues and new challenges]. Calza L; Manfredi R; Chiodo F Recenti Prog Med; 2006 Dec; 97(12):771-80. PubMed ID: 17252736 [TBL] [Abstract][Full Text] [Related]
46. Cardiovascular disease in human immunodeficiency virus. Cheruvu S; Holloway CJ Intern Med J; 2014 Apr; 44(4):315-24. PubMed ID: 24754684 [TBL] [Abstract][Full Text] [Related]
47. HIV infection, aging and cardiovascular disease: epidemiology and prevention. Petoumenos K; Worm SW Sex Health; 2011 Dec; 8(4):465-73. PubMed ID: 22127031 [TBL] [Abstract][Full Text] [Related]
48. Endothelial and platelet function alterations in HIV-infected patients. Gresele P; Falcinelli E; Sebastiano M; Baldelli F Thromb Res; 2012 Mar; 129(3):301-8. PubMed ID: 22192157 [TBL] [Abstract][Full Text] [Related]
49. Secondary complications and co-infections in the HIV-infected adolescent in the antiretroviral era. Ross AC; Camacho-Gonzalez A; Chahroudi A; Chakraborty R Curr Opin Infect Dis; 2011 Jun; 24(3):212-8. PubMed ID: 21455061 [TBL] [Abstract][Full Text] [Related]
50. HIV medications: an update and review of metabolic complications. Hester EK Nutr Clin Pract; 2012 Feb; 27(1):51-64. PubMed ID: 22307491 [TBL] [Abstract][Full Text] [Related]
51. Lipid metabolism and cardiovascular risk in HIV infection: new perspectives and the role of nevirapine. Podzamczer D AIDS Rev; 2013; 15(4):195-203. PubMed ID: 24192600 [TBL] [Abstract][Full Text] [Related]
52. Primary, secondary, and tertiary prevention of cardiovascular disease in patients with HIV disease: a guide for nurse practitioners. Jones-Parker H J Assoc Nurses AIDS Care; 2012; 23(2):124-33. PubMed ID: 22001083 [TBL] [Abstract][Full Text] [Related]
53. Arterial hypertension and cardiovascular risk in HIV-infected patients. Calò LA; Caielli P; Maiolino G; Rossi G J Cardiovasc Med (Hagerstown); 2013 Aug; 14(8):553-8. PubMed ID: 23807242 [TBL] [Abstract][Full Text] [Related]
54. Antiretroviral molecules and cardiovascular diseases. Gibellini D; Borderi M; Clò A; Morini S; Miserocchi A; Bon I; Re MC New Microbiol; 2012 Oct; 35(4):359-75. PubMed ID: 23109004 [TBL] [Abstract][Full Text] [Related]
56. Bone disease in the setting of HIV infection: update and review of the literature. Castronuovo D; Cacopardo B; Pinzone MR; Di Rosa M; Martellotta F; Schioppa O; Moreno S; Nunnari G Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2413-9. PubMed ID: 24089217 [TBL] [Abstract][Full Text] [Related]
57. Human immunodeficiency virus and menopause. Kanapathipillai R; Hickey M; Giles M Menopause; 2013 Sep; 20(9):983-90. PubMed ID: 23531684 [TBL] [Abstract][Full Text] [Related]
58. Venous and arterial thrombosis associated with HIV infection. Dentali F; Nicolini E; Ageno W Semin Thromb Hemost; 2012 Jul; 38(5):524-9. PubMed ID: 22399303 [TBL] [Abstract][Full Text] [Related]
59. HIV infection and cardiovascular disease. Hemkens LG; Bucher HC Eur Heart J; 2014 Jun; 35(21):1373-81. PubMed ID: 24408888 [TBL] [Abstract][Full Text] [Related]